Literature DB >> 18366012

Embryonic stem cells markers are present within rabbit atherosclerotic plaques.

Anthony Zulli1, Brian F Buxton, M Jane Black, David L Hare.   

Abstract

UNLABELLED: Recent evidence suggests that smooth muscle cells within atherosclerotic plaques originate from vascular progenitor cells. We have previously shown that smooth muscle cells and macrophages present within rabbit atherosclerotic plaques are positive for factors of the renin angiotensin and nitric oxide systems as well as the hematopoietic stem-cell marker CD34 and the pan-leukocyte marker CD45. To explore the idea that these cells are of primitive types, immunohistochemistry was used to identify pluripotent embryonic stem cells (ESC) markers (Oct-4, SSEA1,3,4, TRA1-60, 81) in these plaques and to compare these to intimal thickening.
OBJECTIVE: To immunolocalise ESC markers in rabbit aortic intimal thickening and atherosclerotic plaques.
DESIGN: New Zealand White rabbits were fed either a control (Con) diet, 0.5% cholesterol (Chol) or 1% methionine (Meth) for 12 weeks. Animals were perfusion fixed, aortae excised and processed for paraffin. Immunohistochemistry was performed by standard techniques.
RESULTS: Oct-4, SSEA 1, 3 and 4, TRA-1-60 and TRA-1-81 were all present within in atherosclerotic plaques. However, some cells were not positive for TRA-1-60 and TRA-1-81. In fact, positive TRA-1-81 macrophages were uncommon, and positive TRA-1-81 smooth muscle cells were rare. Intimal thickening in Meth did not show any TRA-1-81 positive cells
CONCLUSIONS: Macrophages and smooth muscle cells within atherosclerotic plaques express markers of ESC. These results suggest that cells within these plaques are primitive and might differentiate into other types of cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366012     DOI: 10.14670/HH-23.741

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  7 in total

1.  High dietary methionine plus cholesterol stimulates early atherosclerosis and late fibrous cap development which is associated with a decrease in GRP78 positive plaque cells.

Authors:  Anthony Zulli; David L Hare
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

Authors:  Peter J Wookey; Anthony Zulli; David L Hare
Journal:  Histochem Cell Biol       Date:  2009-04-29       Impact factor: 4.304

3.  High dietary taurine inhibits myocardial apoptosis during an atherogenic diet: association with increased myocardial HSP70 and HSF-1 but not caspase 3.

Authors:  M Setyarani; A Zinellu; C Carru; A Zulli
Journal:  Eur J Nutr       Date:  2013-10-22       Impact factor: 5.614

4.  Proteomic analyses reveal common promiscuous patterns of cell surface proteins on human embryonic stem cells and sperms.

Authors:  Bin Gu; Jiarong Zhang; Ying Wu; Xinzong Zhang; Zhou Tan; Yuanji Lin; Xiao Huang; Liangbiao Chen; Kangshou Yao; Ming Zhang
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

5.  Profiling natural serum antibodies of non-human primates with a carbohydrate antigen microarray.

Authors:  Yoshihide Nanno; Eric Sterner; Jeffrey C Gildersleeve; Bernhard J Hering; Christopher Burlak
Journal:  Xenotransplantation       Date:  2019-11-24       Impact factor: 3.788

6.  Effects of Cervical Rotatory Manipulation (CRM) on Carotid Atherosclerosis Plaque in Vulnerability: A Histological and Immunohistochemical Study Using Animal Model.

Authors:  Ji Qi; Ruiyue Ping; Shaoqun Zhang; Yanxiao Xu; Kai Wu; Yikai Li
Journal:  Biomed Res Int       Date:  2019-02-04       Impact factor: 3.411

7.  Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques.

Authors:  Anthony Zulli; Sudarshan Rai; Brian F Buxton; Louise M Burrell; David L Hare
Journal:  Exp Physiol       Date:  2008-01-11       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.